Disease / condition

Solid Tumor clinical trials

Free access to 440 studies·10+ countries·Updated daily166 recruiting
440
Total trials
10+
Countries
10+
Sponsors
166
Recruiting
By phase
Phase 1275
N/A49
Phase 243
Phase 1/242
Early Phase 124
By status
Recruiting166
Completed119
Not yet recruit...82
Unknown26
Terminated26
Top countries
China127
United States of America122
Japan18
South Korea16
France8
Top sponsors
Jiangsu HengRui Me...11
Eli Lilly and Comp...9
Hoffmann-La Roche8
Athenex, Inc.8
Genentech, Inc.7
Recent trials
Latest clinical trials for Solid Tumor
NCT06416436·Phase 1Not yet recr...
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
University of Kansas Medical C...United States of America
NCT06410092·Phase 1Recruiting
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
Sound Biopharmaceuticals Ltd.China
NCT06394622·Phase 1Recruiting
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors
Fudan UniversityChina
NCT06384807·Phase 1/2Not yet recr...
A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors
Pyramid BiosciencesUnited States of America
NCT06383598Recruiting
PD-L1 Specific [68Ga]-Nb-1 Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospi...China
NCT06364696·Phase 1Recruiting
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
Astellas Pharma IncUnited States of America
NCT06368921·Phase 1Recruiting
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Guangzhou Virotech Pharmaceuti...China
NCT06349837·Phase 1Not yet recr...
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Sichuan University
NCT06336148·Phase 1Not yet recr...
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.Australia
NCT06342336·Phase 1Recruiting
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine ...China
NCT06327997·Phase 1Recruiting
An Exploratory Study by Fast CAR T Cells
Shanghai Cell Therapy Group Co...China
NCT06337630·Phase 1Not yet recr...
A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors
Institut CurieFrance
NCT06326242Recruiting
What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
European Institute of OncologyItaly
NCT06310655Recruiting
Online Proton Adaptive Radiotherapy
Washington University School o...United States of America
NCT06308263·Phase 1Recruiting
M1774 Human Mass Balance Study (DDRIVER Solid Tumors 303)
Merck Healthcare KGaA, Darmsta...Hungary
NCT06297525·Phase 1Not yet recr...
Study of STP938 in Advanced Solid Tumours
Step Pharma, SAS
NCT06299761·Phase 1Recruiting
Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications
Boundless BioUnited States of America
NCT06290388·Phase 1/2Recruiting
Study of 23ME-01473 in Patients With Advanced Solid Malignancies
23andMe, Inc.United States of America
NCT06249256·Phase 1Recruiting
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Shanghai Cell Therapy Group Co...China
NCT06248697·Phase 1Recruiting
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Shanghai Cell Therapy Group Co...China
About this record

Access comprehensive clinical trial information for Solid Tumor through Pure Global AI's free database. This collection includes 440 clinical trials across multiple phases including Phase 1, N/A, Phase 2. Currently, 166 trials are actively recruiting participants.

Research for Solid Tumor is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include Jiangsu HengRui Medicine Co., Ltd. and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 440 clinical trials studying Solid Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Jiangsu HengRui Medicine Co., Ltd., Eli Lilly and Company, Hoffmann-La Roche, among others.